Patheon Announces Expansion of Manati Puerto Rico Facility for High Potency Manufacturing
Patheon Inc. announced it will expand the Manati, Puerto Rico facility to add a dedicated high potency and controlled substance manufacturing area. Patheon will invest a total of $2.8 million in this new 3,386ft(2) area that will include three manufacturing suites, air lock containment areas, and humidity controlled air systems.
The three manufacturing suites will enable Patheon to combine in one manufacturing area technology transfer, bulk production, bulk packaging, and storage. The production area will have capacity for high potency (containment down to 1 (micro)g/m(3) OEL) and humidity controlled solid dosage form products. The construction project is currently in a fast track mode with completion expected, based on current activity, by the end of September 2008. Patheon has been contracted by one customer to utilize the suites and the expansion will also provide substantial capacity to serve additional high-potency projects.
"The Manati expansion is part of our strategy to satisfy the special manufacturing needs of our current and future customers," stated Terry Novak, President of North America and Chief Marketing Officer. "Other Patheon sites have extensive capabilities to manufacture products of this type. The addition of this capability in Puerto Rico provides another high quality manufacturing site option to our customers."
Other news from the department manufacturing
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
